Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process

Pediatrics
D J CiskeP M Farrell

Abstract

To assess the effectiveness of communication between health care providers (physicians, nurses, genetic counselors) in Wisconsin and parents of children identified as heterozygote carriers for cystic fibrosis (CF) in the routine Wisconsin Newborn Screening Program that was implemented using trypsinogen/DNA testing. Routine CF neonatal screening, implemented in July 1994, involved a statewide system that recommended but did not mandate follow-up sweat tests at 1 of the Wisconsin's 2 certified CF centers. The Wisconsin Division of Health sent requests to participate to the parents of 483 infants identified as CF carriers between July 1994 and December 1997. Of the 483 parents, 183 agreed to participate and were asked to complete a questionnaire assessing their CF newborn screening experiences and their knowledge of CF genetics and any changes they made in their reproductive behavior as a result of this knowledge. Follow-up telephone interviews by a genetic counselor were attempted within 1 year for those completing the questionnaire. Within 4 months after the mailing, 138 of 183 (75%) parents completed the questionnaire. Subsequently, 123 of the 138 responders (89%) were contacted and interviewed by telephone. We learned that 67....Continue Reading

Citations

Feb 6, 2007·Journal of Genetic Counseling·James Price DillardPhilip Farrell
Oct 8, 2009·Journal of Genetic Counseling·Tabitha A HarrisonTrish Brown
Feb 5, 2010·Journal of Genetic Counseling·Laura CavanaghPhilip M Farrell
Dec 6, 2003·The Journal of Pediatrics·Michael H Farrell, Philip M Farrell
Jun 7, 2008·The Journal of Pediatrics·Anne MunckMichel Roussey
Nov 25, 2003·Paediatric Respiratory Reviews·Bridget Wilcken, Veronica Wiley
Nov 25, 2003·Paediatric Respiratory Reviews·Evelyn P Parsons, Donald M Bradley
Mar 12, 2009·European Journal of Human Genetics : EJHG·Pascal BorryUNKNOWN Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG)
Mar 2, 2012·European Journal of Human Genetics : EJHG·Yvonne Bombard, Fiona A Miller
Oct 18, 2005·Genetic Testing·Erin LagoePeter T Rowley
Jun 14, 2003·Current Opinion in Pediatrics·Jeffrey S WagenerFrank J Accurso
Nov 14, 2001·Current Opinion in Pulmonary Medicine·S S YoungG Cunningham
Oct 26, 2005·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Diane B ThompsonSusan A Berry
Aug 21, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jean JenkinsIlan R Kirsch
Aug 21, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Celia I KayeBradford L Therrell
May 7, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Beth KladnyLakshmanan Krishnamurti
Nov 17, 2009·The Journal of Perinatal & Neonatal Nursing·Audrey TluczekRoger L Brown
Aug 24, 2006·Journal of Paediatrics and Child Health·Sharon LewisJohn Massie
Sep 21, 2010·Qualitative Health Research·Audrey TluczekLaura Cavanagh
Sep 18, 2012·Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community·Natalie SalmAudrey Tluczek
Jun 20, 2007·BMC Medical Education·Eduardo Rosas-BlumMarie Leiner
Dec 9, 2008·American Journal of Public Health·Fiona Alice MillerRobin Z Hayeems
Jul 11, 2014·Journal of Genetic Counseling·Melissa NokeFiona Ulph
Sep 17, 2014·Patient Education and Counseling·Michael H FarrellPhilip M Farrell
Oct 24, 2002·Current Opinion in Pulmonary Medicine·Benjamin Wilfond, L S Rothenberg
Mar 20, 2014·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Audrey Tluczek, Jane M De Luca
Jan 12, 2016·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Corina S RueeggUNKNOWN Swiss Cystic Fibrosis Screening Group
Nov 19, 2008·The Journal of Pediatrics·Zafer N SoultanRan D Anbar
Nov 14, 2015·European Journal of Medical Genetics·D F Vears, S A Metcalfe
May 1, 2007·Clinics in Chest Medicine·Michael J Rock
Nov 22, 2012·Pediatric Pulmonology·Mary J KleynSamya Z Nasr
Nov 27, 2014·Annals of Neurology·Michele A ScullyJennifer M Kwon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.